| It’s the latest in a string of lawsuits from health insurers scrambling to protect their prized quality scores and the money those ratings represent. |
| Senate report slams Medicare Advantage insurers for using predictive technology to deny claims UnitedHealth, CVS and Humana used technology to increase MA prior authorization denials for post-acute services, boosting profits, according to a report from a Senate subcommittee. from STAT: first opinion Should PCPs perform abortions? To be clear: In many places, it’s already happening. Family physicians are currently the second-most common providers of abortion care in the U.S., providing 17% of medication abortions and 7% of procedural abortions. They’re also one of the largest groups of active physicians, and in rural areas, they’re often the only physicians.In a First Opinion essay, a family physician and OB/GYN argue together that PCPs are in a prime position to provide comprehensive, widespread abortion care. Currently, one in five patients travels out of state to get abortion care. But decades of research show that primary care physicians can provide abortion care safely and effectively, in familiar office settings and with more personalized care. from AXIOS:IV fluid airlift underway to relieve shortagesBy Maya Goldman  Illustration: Eniola Odetunde/Axios IV fluids from as far away as China are being flown to the U.S. to alleviate nationwide shortages stemming from hurricane damage to a key manufacturing plant in North Carolina.Why it matters: Hospitals now have 50% more IV fluid available to them than immediately after Hurricane Helene swamped Baxter International’s North Cove manufacturing site in Marion, North Carolina, per HHS. But providers expect shortages to last weeks longer.State of play: The first IV fluids imported from Baxter facilities in other countries reached the U.S. on Saturday, HHS said.The FDA has authorized temporary importation from Baxter plants in Canada, China, Ireland and the U.K., the company said. Baxter is working with the FDA to authorize imports from its other international sites.Baxter, working with HHS’s Administration for Strategic Preparedness and Response, expects to deliver nearly 18,000 tons of products from Europe and Asia by the end of the year.The FDA has also added more IV solutions to the drug shortage list, which allows for the distribution of compounded substances Meanwhile, pre-hurricane staffing levels will resume at Baxter’s North Carolina plant this week, the company said on Monday. |
Leave a Reply